Bringing the fundamentals into focus…
Back to Cytokinetics, Incorporated
How Cytokinetics, Incorporated stacks up
CYTK · against 173 other Healthcare companies of similar size
Overall
26/ 100
Near the bottom of its peers.
Ranked #170 of 174 · scores higher than 2% of peers
Bars: peers in each 10-point band of the overall score8 peers with an overall score of 20–29, including CYTK · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around CYTK| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 37.3B HKD (≈$4.8B) | 90 | 99 | 98 | 84 | 0 / 2 | |
| 2 | 921.9B INR (≈$11.1B) | 82 | 84 | 80 | 94 | 0 / 2 | |
| 3 | 936.1B JPY (≈$6.4B) | 80 | 65 | 86 | 94 | 0 / 2 | |
| 4 | 10.7B USD | 78 | 77 | 85 | 84 | 0 / 2 | |
| 4 | 9.0B USD | 78 | 50 | 80 | 94 | 0 / 2 | |
| 167 | 8.4B USD | 28 | 8 | 74 | 21 | 2 / 2 | |
| 167 | 8.5B USD | 28 | 8 | 37 | 26 | 1 / 2 | |
| 169 | 4.8B USD | 27 | 8 | 5 | 5 | 0 / 2 | |
| 170 | 31.0B CNY (≈$4.3B) | 26 | 0 | 4 | 29 | 0 / 2 | |
| 170 | 8.7B USD | 26 | 8 | 78 | 2 | 2 / 2 | |
| 172 | 5.4B USD | 24 | 8 | — | 8 | 1 / 2 | |
| 173 | 6.7B USD | 19 | 8 | 30 | 20 | 2 / 2 | |
| 174 | 34.9B CNY (≈$4.9B) | 16 | 0 | 0 | 22 | 1 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score